Valuation: Optiscan Imaging Limited

Market Cap 125M 87.72M 76.88M 71.07M 65.36M 123M 8.46B 850M 333M 4.14B 329M 322M 14.26B P/E 2024
-31.8x
P/E 2025 -14.5x
Enterprise Value 122M 85.57M 75M 69.32M 63.76M 120M 8.25B 829M 325M 4.04B 321M 314M 13.91B EV / Sales 2024
62.1x
EV / Sales 2025 23.8x
Free-Float
36.32%
Yield 2024 *
-
Yield 2025 -
Current month+29.17%
1 month+24.00%
3 months+40.91%
6 months+76.14%
Current year+55.00%
1 week 0.15
Extreme 0.15
0.16
1 month 0.12
Extreme 0.12
0.16
Current year 0.08
Extreme 0.08
0.16
1 year 0.08
Extreme 0.079
0.16
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.29
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 2021-12-12
Director of Finance/CFO - 2025-03-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2021-04-18
Director/Board Member - 2022-06-13
Director/Board Member - 2021-07-28
Date Insider Type Main position Quantity % Market Cap.
5/22/26 Sell

Director

-3,000,000 0.2873%
1/15/26 Free

Chief Executive Officer

1,191,962 0.1142%
1/15/26 Free

Director

230,502 0.0221%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+34.78%+80.23% 113M
+6.91%+8.87%-7.74%-12.60% 13.35B
-2.62%-10.96%+37.34%-12.44% 3.86B
0.00%-0.68%+71.16%+108.49% 1.24B
+1.96%+1.10%-33.97%-59.49% 1.18B
+1.04%-0.28%-39.88%-45.92% 1.09B
+0.40%+7.25%-42.58% - 940M
-4.05%-16.17%+54.47%+83.21% 490M
+0.60%+8.52%+48.35% - 335M
+1.09%+4.24%-56.19%+242.71% 265M
Average +0.53%-0.32%+6.57%+48.02% 2.29B
Weighted average by Cap. +3.69%+1.94%+1.62%-4.08%

Financials

2024 2025
Net sales 2.99M 2.09M 1.83M 1.69M 1.56M 2.94M 202M 20.25M 7.94M 98.63M 7.85M 7.68M 340M 3.72M 2.61M 2.29M 2.11M 1.94M 3.67M 251M 25.26M 9.9M 123M 9.79M 9.58M 424M
Net income -6.06M -4.24M -3.72M -3.44M -3.16M -5.96M -409M -41.1M -16.11M -200M -15.93M -15.58M -690M -6.31M -4.42M -3.87M -3.58M -3.29M -6.21M -426M -42.81M -16.78M -208M -16.59M -16.23M -718M
Net Debt -11.01M -7.71M -6.76M -6.25M -5.74M -10.84M -743M -74.67M -29.27M -364M -28.94M -28.31M -1.25B -3.07M -2.15M -1.88M -1.74M -1.6M -3.02M -207M -20.83M -8.16M -101M -8.07M -7.9M -349M
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
26-07-20 A$0.1550 0.00% 98
26-07-20 A$0.1550 0.00% 171,537
26-07-17 A$0.1550 0.00% 132,048
26-07-16 A$0.1550 0.00% 145,965
26-07-15 A$0.1550 0.00% 153,558